SB2733: NPLEx; require manufacturers of certain pseudoephedrine or ephedrine products to pay fees to support the administration of.
Legislative Summary
An Act To Amend Section 73-21-124, Mississippi Code Of 1972, To Provide That As Of October 1, 2025, Any Manufacturer Of Any Lawful Pseudoephedrine Or Ephedrine Product That Is Sold In Or Into The State Must Pay Monthly Fees To The National Association Of Drug Diversion Investigators To Support The Administration Of The National Precursor Log Exchange (nplex); To Provide That The National Association Of Drug Diversion Investigators Shall Set Such Fees; To Require Manufacturers Required To Pay Such Fees To Provide, At The Request Of The Mississippi State Board Of Pharmacy, Written Documentation Demonstrating Payment Of The Fees; To Clarify Provisions; And For Related Purposes.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
Status Information
Sponsors
Primary Sponsor
